Applied dna to participate in upcoming conferences

Stony brook, n.y.--(business wire)---- $apdn #covid19--applied dna sciences, inc. (nasdaq: apdn) (“applied dna” or the “company”), a leader in polymerase chain reaction (pcr)-based dna manufacturing, will be participating in the following virtual investor conferences. march 9 – 10, 2021 – dr. james a. hayward, president and ceo, will present a company overview at the h.c. wainwright global life sciences virtual conference. dr. hayward and beth jantzen, chief financial officer, will also hold virtual investor meet
APDN Ratings Summary
APDN Quant Ranking